TY - JOUR
T1 - 64Cu-Labeled CB-TE2A and diamsar-conjugated RGD peptide analogs for targeting angiogenesis
T2 - comparison of their biological activity
AU - Wei, Lihui
AU - Ye, Yunpeng
AU - Wadas, Thaddeus J.
AU - Lewis, Jason S.
AU - Welch, Michael J.
AU - Achilefu, Samuel
AU - Anderson, Carolyn J.
PY - 2009/4
Y1 - 2009/4
N2 - Objectives: The αvβ3 integrin is a cell adhesion molecule known to be involved in stages of angiogenesis and metastasis. In this study, the chelators CB-TE2A and diamsar were conjugated to cyclic RGDyK and RGDfD and the biological properties of 64Cu-labeled peptides were compared. Methods: CB-TE2A-c(RGDyK) and diamsar-c(RGDfD) were labeled with 64Cu in 0.1 M NH4OAc (pH=8) at 95°C and 25°C, respectively. PET and biodistribution studies were carried out on M21 (αvβ3-positive) and M21L (αv-negative) melanoma-bearing mice. Binding affinity of the Cu-chelator-RGD peptides to αvβ3 integrins was determined by a competitive binding affinity assay. Results: Biological studies showed higher concentration of 64Cu-CB-TE2A-c(RGDyK) in M21 tumor compared to M21L tumor at 1 and 4 h pi. Tumor concentration of 64Cu-CB-TE2A-c(RGDyK) was higher than that of 64Cu-diamsar-c(RGDfD). The difference is not due to differing binding affinities, since similar values were obtained for the agents. Compared to 64Cu-diamsar-c(RGDfD), there is more rapid liver and blood clearance of 64Cu-CB-TE2A-c(RGDyK), resulting in a lower liver and blood concentration at 24 h pi. Both 64Cu-labeled RGD peptides show similar binding affinities to αvβ3. The differences in their biodistribution properties are likely related to different linkers, charges and lipophilicities. The M21 tumor is clearly visualized with 64Cu-CB-TE2A-c(RGDyK) by microPET imaging. Administration of c(RGDyK) as a block significantly reduced the tumor concentration; however, the radioactivity background was also decreased by the blocking dose. Conclusions: Both 64Cu-CB-TE2A-c(RGDyK) and 64Cu-diamsar-c(RGDfD) are potential candidates for imaging tumor angiogenesis. For diamsar-c(RGDfD), a linker may be needed between the Cu-chelator moiety and the RGD peptide to achieve optimal in vivo tumor concentration and clearance from nontarget organs.
AB - Objectives: The αvβ3 integrin is a cell adhesion molecule known to be involved in stages of angiogenesis and metastasis. In this study, the chelators CB-TE2A and diamsar were conjugated to cyclic RGDyK and RGDfD and the biological properties of 64Cu-labeled peptides were compared. Methods: CB-TE2A-c(RGDyK) and diamsar-c(RGDfD) were labeled with 64Cu in 0.1 M NH4OAc (pH=8) at 95°C and 25°C, respectively. PET and biodistribution studies were carried out on M21 (αvβ3-positive) and M21L (αv-negative) melanoma-bearing mice. Binding affinity of the Cu-chelator-RGD peptides to αvβ3 integrins was determined by a competitive binding affinity assay. Results: Biological studies showed higher concentration of 64Cu-CB-TE2A-c(RGDyK) in M21 tumor compared to M21L tumor at 1 and 4 h pi. Tumor concentration of 64Cu-CB-TE2A-c(RGDyK) was higher than that of 64Cu-diamsar-c(RGDfD). The difference is not due to differing binding affinities, since similar values were obtained for the agents. Compared to 64Cu-diamsar-c(RGDfD), there is more rapid liver and blood clearance of 64Cu-CB-TE2A-c(RGDyK), resulting in a lower liver and blood concentration at 24 h pi. Both 64Cu-labeled RGD peptides show similar binding affinities to αvβ3. The differences in their biodistribution properties are likely related to different linkers, charges and lipophilicities. The M21 tumor is clearly visualized with 64Cu-CB-TE2A-c(RGDyK) by microPET imaging. Administration of c(RGDyK) as a block significantly reduced the tumor concentration; however, the radioactivity background was also decreased by the blocking dose. Conclusions: Both 64Cu-CB-TE2A-c(RGDyK) and 64Cu-diamsar-c(RGDfD) are potential candidates for imaging tumor angiogenesis. For diamsar-c(RGDfD), a linker may be needed between the Cu-chelator moiety and the RGD peptide to achieve optimal in vivo tumor concentration and clearance from nontarget organs.
KW - CB-TE2A
KW - Copper-64
KW - Diamsar
KW - RGD
UR - http://www.scopus.com/inward/record.url?scp=62549139647&partnerID=8YFLogxK
U2 - 10.1016/j.nucmedbio.2008.12.008
DO - 10.1016/j.nucmedbio.2008.12.008
M3 - Article
C2 - 19324273
AN - SCOPUS:62549139647
SN - 0969-8051
VL - 36
SP - 277
EP - 285
JO - Nuclear Medicine and Biology
JF - Nuclear Medicine and Biology
IS - 3
ER -